AIHTA - Publications - Search - Browse by Person
Number of items: 17.

Semlitsch, T. and Loder, C. (2020): Leadless pacemaker for right ventricle pacing (Update 2020). Decision Support Document 97/ Update 2020.

Semlitsch, T. and Jeitler, K. and Zipp, C. and Krenn, C. and Horvath, K. and Zens, Y. and Hausner, E. and Sauerland, S. and Störchel, M. and Sturtz, S. and Varela Lema, L. and Paz Valiñas, L. and Puñal Riobóo, J. and Cantero Muñoz, P. and Faraldo Vallés, M.J. (2020): Lung cancer screening in risk groups. HTA-Projektbericht 132a.

Semlitsch, T. and Zipp, C. and Loder, C. (2022): Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022. Decision Support Document 64/ Update 2022.

Semlitsch, T. and Loder, C. (2023): Percutaneous mitral valve repair with a clip device in patients with mitral regurgitation. 2nd Update 2023. Decision Support Document 41/ Update 2023.

Semlitsch, T. and Krenn, C. (2024): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) in patients with coronary artery disease (CAD). 3rd Update. Decision Support Document 24/ 3. Update 2024.

Jeitler, K. and Semlitsch, T. (2012): Bevacizumab (Avastin®) in combination with chemotherapy in previously treated metastatic breast cancer. DSD: Horizon Scanning in Oncology 27.

Semlitsch, T. and Zengerer, A. and Jeitler, K. (2013): Dabrafenib (Tafinlar®) in previously untreated subjects with BRAF mutation-positive advanced (stage III) or metastatic (stage IV) melanoma. DSD: Horizon Scanning in Oncology 42.

Semlitsch, T. and Horvath, K. (2019): Screening for Diabetes mellitus: guideline recommendations. HTA-Projektbericht 118.

Semlitsch, T. and Ciutan, M. and Scintee, S.G. (2019): Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report. Decision Support Document 81/ Update 2019.

Jeitler, K. and Semlitsch , T. (2012): Everolimus (Afinitor® or Votubia®) in combination with exemestane in postmenopausal women with oestrogen receptor positive, HER2-negative locally advanced or metastatic breast cancer who are refractory to letrozole or anastrozole. DSD: Horizon Scanning in Oncology 32.

Semlitsch , T. and Jeitler, K. (2013): Crizotinib (Xalkori®) for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) . DSD: Horizon Scanning in Oncology 35.

Semlitsch, T. and Posch, N. (2017): Percutaneous disc volume reduction with focus on chemonucleolysis. Update 2017. Decision Support Document 21/ 1. Update 2017.

Semlitsch, T. and Posch, N. (2017): Leadless pacemakers for right ventricle pacing. Update 2017. Decision Support Document 97/ 1. Update 2017.

Semlitsch, T. and Zengerer, A. and Jeitler, K. (2014): Nab-Paclitaxel (Abraxane®) as first-line therapy for metastatic adenocarcinoma of the pancreas. DSD: Horizon Scanning in Oncology 43.

Semlitsch, T. and Geiger-Gritsch, S. (2019): Annulus Fibrosus Repair after lumbar discectomy . Decision Support Document 65/ Update 2019.

Semlitsch, T. and Horvath, K. (2016): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016 . Decision Support Document 24/ 2. Update 2016.

Semlitsch, T. and Krenn, C. (2018): (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018. Decision Support Document 44/ Update 2018.

This list was generated on Sun Nov 10 00:00:22 2024 CET.